CONSIDERATIONS TO KNOW ABOUT API PHARMACEUTICAL

“The present scenario has uncovered some structural weaknesses in the EU’s medicines source chain plus a higher dependence on non-EU nations for active pharmaceutical ingredients,” Kyriakides said. She recommended that offer chain concerns be addressed in an EU pharmaceutical technique envisioned to be launched by the tip of the yr.S. marketp